Company Directory / research

PrivateFor profitresearchCanberra, Australia
GPN Vaccines is a vaccine that is used to prevent the spread of streptococcus pneumoniae.
Size
11-50 people: larger than 33% of companies with a size listed
Age
9 years old.
Reach
Website ranked #13,654,865 in the world for traffic, about 75 visits a month.
Biotechnology
Funding, as listed
$36M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about GPN Vaccines, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
GPN Vaccines may be growing as evidenced by their expanded partnership with BioCina for the development and manufacturing of pneumococcal vaccines. The collaboration indicates an increase in operational capabilities and potential market reach for GPN Vaccines. Furthermore, the deal with BioCina, a known entity in the bioprocess industry, suggests a strategic move to enhance GPN Vaccines' production capacity and distribution channels.
Summaries written by the source dataset, not by us, and not checked.
research in Australia.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 128,574 companies in Australia and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.